Illumina (ILMN) Cash from Financing Activities (2009 - 2026)
Illumina (ILMN) reported Cash from Financing Activities of -$251.0 million for Q1 2026, down 28.72% on a YoY basis from -$352.1 million in Q1 2025, and down 298.41% quarter-over-quarter from -$63.0 million in Q4 2025.
Illumina (ILMN) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Illumina has reported Cash from Financing Activities for 18 years, with the latest figure at -$251.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 28.72% year-over-year to -$251.0 million; the trailing twelve-month figure through Mar 2026 stood at -$800.0 million (changed 0.0% YoY), and the FY2025 full-year result was -$744.0 million, down 30.53% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$251.0 million, down from -$63.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $922.0 million in Q1 2023, with the low at -$707.0 million in Q4 2023.
- Historically, Cash from Financing Activities has averaged -$122.1 million across 5 years, with a median of -$115.0 million in 2025.
- The largest YoY upside for Cash from Financing Activities was 107.4% in 2024 against a maximum downside of 7433.33% in 2024.
- Illumina's Cash from Financing Activities stood at $21.0 million in 2022, then slumped by 228.57% to -$27.0 million in 2023, then tumbled by 74.07% to -$47.0 million in 2024, then sank by 34.04% to -$63.0 million in 2025, then plunged by 298.41% to -$251.0 million in 2026.
- The last three Cash from Financing Activities figures came in at -$251.0 million (Q1 2026), -$63.0 million (Q4 2025), and -$115.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | -152.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -251.00 Mn |
| Mar 29, 2026 | -251.00 Mn |
| Dec 28, 2025 | -63.00 Mn |
| Dec 28, 2025 | -63.00 Mn |
| Sep 28, 2025 | -115.00 Mn |
| Sep 28, 2025 | -115.00 Mn |
| Jun 29, 2025 | -371.00 Mn |
| Jun 29, 2025 | -371.00 Mn |
| Mar 30, 2025 | -195.00 Mn |
| Mar 30, 2025 | -195.00 Mn |
| Dec 29, 2024 | -47.00 Mn |
| Dec 29, 2024 | -47.00 Mn |
| Sep 29, 2024 | -332.00 Mn |
| Sep 29, 2024 | -332.00 Mn |
| Jun 30, 2024 | -226.00 Mn |
| Jun 30, 2024 | -226.00 Mn |
| Mar 31, 2024 | 35.00 Mn |
| Mar 31, 2024 | 35.00 Mn |
| Dec 31, 2023 | -27.00 Mn |
| Dec 31, 2023 | -27.00 Mn |